Literature DB >> 17766036

Epidemiology of multiple sclerosis in western Herzegovina.

Inge Klupka-Sarić1, Smiljana Ristić, Juraj Sepcić, Miljenko Kapović, Borut Peterlin, Eris Materljan, Tonka Jurisić, Drazena Martinović Mamić, Adnan Burina, Vlatko Sulentić.   

Abstract

OBJECTIVES: To determine epidemiological rates of multiple sclerosis (MS) in western Herzegovina. PATIENTS AND METHODS: We analysed data from 81 MS patients (49 females, 32 males) on the prevalence day, 31 December 2003. Patient information was obtained from a search of all available medical records from the period 1994-2003 in the investigated area.
RESULTS: Crude prevalence of MS was 27/100,000 (95% confidence interval (CI) 20-34). Prevalence was highest in the mountainous municipality of Posusje (56/100,000) and lowest in the coastal municipality of Neum (0 incidence). The annual incidence of MS was 1.6/100,000 (95% CI 0-3.3). The female/male ratio of MS was 1.5. The mean age of the patients on prevalence day was 40.0+/-11.6 years, and the mean age at disease onset was 31.0+/-7.1 years. Eight (10%) of the patients had a first-degree relative with MS. The primary progressive (PP) disease course was observed only in females. Visual symptoms were the initial symptom of MS in 6 (7%) of the patients.
CONCLUSIONS: Western Herzegovina is an area of moderate risk for MS, and the distribution of MS in western Herzegovina is heterogeneous. PP-MS occurred only in females, and involvement of the visual pathways as the initial symptom of MS was low.

Entities:  

Mesh:

Year:  2007        PMID: 17766036     DOI: 10.1016/j.clineuro.2007.07.014

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

Review 1.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

2.  Epidemiological characteristics and functional disability of multiple sclerosis patients in kosovo.

Authors:  Kamber Zeqiraj; Jera Kruja; Serbeze Kabashi; Sefedin Muçaj
Journal:  Med Arch       Date:  2014-05-31

3.  How Cost-of-Illness (COI) Study Provides Direct and Indirect Costs of Multiple Sclerosis (MS) in Bosnia and Herzegovina ?

Authors:  Tarik Catic; Enra Suljic; Refet Gojak; Josip Culig
Journal:  Mater Sociomed       Date:  2018-12

4.  Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.

Authors:  Vijayalakshmi Vasanthaprasad; Vivek Khurana; Sreelatha Vadapalle; Jackie Palace; Nicholas Adlard
Journal:  BMC Neurol       Date:  2022-08-17       Impact factor: 2.903

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.